USPTO serial 79299574
NEURODERM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 25, 2021
- Examiner
- ADORNO SANTOS, LUZ M.
- Law office
- TMO LAW OFFICE 111
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NEURODERM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, pharmaceutical preparations for use in preventing and treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention and treatment of allergies or allergic responses, metabolic disorders, psychiatric and emotional disorders, infection and infectious diseases, pain; drug delivery kits comprising dressings for medical, surgical, and veterinary use [ ; drug delivery agents, namely, transdermal patches sold with medication for use in the treatment of conditions, diseases or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems ] | ACTIVE | — |
| 010 | Medical devices for delivery of medicated and pharmaceutical preparations, namely, implantable drug delivery pumps, drug delivery catheters, drug delivery patches sold without medication, subcutaneous drug delivery pumps, subcutaneous drug delivery patch pumps, refillable drug delivery pumps, and infusion drug delivery pumps; drug delivery device sold empty, namely, syringes, infusion drug delivery pumps; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, and nutrition, namely, infusion pumps, patch pumps being adherable subcutaneous drug delivery pumps, wearable medication injectors, wearable subcutaneous drug delivery pumps, and handheld medication injectors; medical syringes; medical devices in the nature of infusion pumps for drug infusion and for monitoring the infusion of drugs with integrated recorded software for transmission and receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling and emptying of drug vials, and patient's behavior and reaction to drugs, sold as a unit therewith; drug delivery devices, namely, catheters, injection pen needles, injection needles, injection syringes and implantable subcutaneous drug delivery pumps; lancets; medical lancing devices for delivering medication, sold empty; drug eluting stents; bio-absorbable stents; synthetic stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; medical apparatus for measuring dosages and delivering pharmaceuticals, namely, infusion drug delivery pumps, subcutaneous drug delivery wearable pumps, subcutaneous drug delivery patch pumps, implantable drug delivery pumps and injection pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronickinetic transdermal drug delivery control unit for the treatment of diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 30, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 9, 2022 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Feb 9, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 11, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 11, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 25, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 10, 2021 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jun 9, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 9, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 9, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 25, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 23, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Mar 22, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2021 | ALIE | ASSIGNED TO LIE | — |
| Feb 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 29, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 10, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |